Marizyme, Inc. filed its 10-K on Mar 24, 2023 for the period ending Dec 31, 2022. In this report its auditor, WithumSmith+Brown, PC , gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.055 USD | +3.77% | +3.77% | -45.05% |
06/02 | Marizyme, Inc. Announces Resignation of Julie Kampf from the Board of Directors | CI |
2023 | Marizyme, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
-45.05% | 2.57M | |
+5.33% | 111B | |
+12.11% | 105B | |
-12.56% | 22.34B | |
-3.70% | 21.93B | |
-6.03% | 18.59B | |
-35.21% | 18.12B | |
-10.86% | 16.96B | |
+5.10% | 13.7B | |
+37.57% | 12.45B |
- Stock Market
- Equities
- GBSX Stock
- News Marizyme, Inc.
- Marizyme, Inc. Auditor Raises 'Going Concern' Doubt